Ownership history in Flagship Pioneering, LLC · 21 quarters on record
This page tracks every 13F SEC filing in which Flagship Pioneering, LLC reported a position in Foghorn Therapeutics Inc (FHTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 12,674,120 | — | 0% | 21.12% | $68.4M | $5.40 |
| 2025 Q3 | UNCHANGED | 12,674,120 | — | 0% | 21.18% | $62.0M | $4.89 |
| 2025 Q2 | UNCHANGED | 12,674,120 | — | 0% | 22.19% | $59.6M | $4.70 |
| 2025 Q1 | UNCHANGED | 12,674,120 | — | 0% | 19.62% | $46.26B | $3.65 |
| 2024 Q4 | UNCHANGED | 12,674,120 | — | 0% | 17.90% | $59.82B | $4.72 |
| 2024 Q3 | UNCHANGED | 12,674,120 | — | 0% | 19.94% | $118.0M | $9.31 |
| 2024 Q2 | UNCHANGED | 12,674,120 | — | 0% | 8.64% | $72.9M | $5.75 |
| 2024 Q1 | UNCHANGED | 12,674,120 | — | 0% | 5.58% | $85.0M | $6.71 |
| 2023 Q4 | UNCHANGED | 12,674,120 | — | 0% | 6.17% | $81.7M | $6.45 |
| 2023 Q3 | UNCHANGED | 12,674,120 | — | 0% | 4.60% | $63.37B | $5.00 |
As of 2025 Q4 — sorted by position size